Clinical Trial Update: Oxybutynin Chloride in Managing Hot Flashes [Phase 3]

View source ↗

Summary

Phase 3 trial investigating oxybutynin chloride for managing hot flashes in breast cancer patients; study completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Hot Flashes
• Lobular Carcinoma in Situ

Drugs mentioned

• Oxybutynin chloride (Oxybutynin chloride)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Breast Carcinoma, Ductal Breast Carcinoma In Situ | Phase 3 | Status: COMPLETED | Results posted: 2019-06-03